SAN FRANCISCO, Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback